rosuvastatin hetero 20 mg tabletki powlekane
hetero europe s.l. - rosuvastatinum calicum - tabletki powlekane - 20 mg
rosuvastatin hetero 40 mg tabletki powlekane
hetero europe s.l. - rosuvastatinum calicum - tabletki powlekane - 40 mg
rosuvastatin krka 30 mg tabletki powlekane
krka, d.d., novo mesto - rosuvastatinum - tabletki powlekane - 30 mg
atorvastatin aurovitas 40 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - atorvastatinum calcicum trihydricum - tabletki powlekane - 40 mg
atorvastatin medreg 10 mg tabletki powlekane
medreg s.r.o. - atorvastatinum - tabletki powlekane - 10 mg
atorvastatin medreg 20 mg tabletki powlekane
medreg s.r.o. - atorvastatinum - tabletki powlekane - 20 mg
atorvastatin medreg 40 mg tabletki powlekane
medreg s.r.o. - atorvastatinum - tabletki powlekane - 40 mg
atorvastatin medreg 80 mg tabletki powlekane
medreg s.r.o. - atorvastatinum - tabletki powlekane - 80 mg
porcilis app zawiesina do wstrzykiwań dla świń -toksoid actinobacillus pleuropneumoniae apxi >50 j.m.;-toksoid actinobacillus pleuropneumoniae apxii >50 j.m.;-toksoid actinobacillus pleuropneumoniae apxiii >50 j.m.;-białko otoczki zawierającej (omp) actinobacillus pleuropneumoniae >50 j.m. zawiesina do wstrzykiwań
intervet international b.v. - toksoid actinobacillus pleuropneumoniae apx-i + toksoid actinobacillus pleuropneumoniae apx-iii + toksoid actinobacillus pleuropneumoniae apx-ii + białko otoczki zewnętrznej (omp) actinobacillus pleuropneumoniae - zawiesina do wstrzykiwań - -toksoid actinobacillus pleuropneumoniae apxi >50 j.m.;-toksoid actinobacillus pleuropneumoniae apxii >50 j.m.;-toksoid actinobacillus pleuropneumoniae apxiii >50 j.m.;-białko otoczki zawierającej (omp) actinobacillus pleuropneumoniae >50 j.m. - świnia
vildagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - leki stosowane w cukrzycy - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 dla dostępnych danych o różnych kombinacjach).